Jim brings over 25 years of executive management and operating experience in technology and the healthcare industry, having led early-stage firms as well as large multinational businesses by driving rapid growth, strategic pivots, and turn-arounds. He brings a direct and hands-on approach to strategy and operations in highly competitive and regulated industries.
Prior to joining Armory, Jim focused on solving complex business problems and delivering growth in a variety of healthcare businesses. He served as President and CEO of early-stage respiratory innovator Ventec Life Systems, expanding the business, and driving it to a successful exit. Before that, he was the SVP and GM of the global Hospital Respiratory Care Business Unit of Royal Philips, guiding the company through a ~300% scale up reaching $1B in revenue during the COVID-19 pandemic. As VP of Innovation and Business Development in the Medication Management business at Becton Dickinson, his team launched the first comprehensive Infusion System integration to Hospital IT, establishing a software subscription business driving fast growth in the traditional capital equipment and consumables lines. Previously, he was responsible for innovation and product development in the Carl Zeiss Meditec ophthalmic solutions business. Before a sale to LivaNova PLC, Jim served on the board of ALung, Inc., an innovator in ECMO-related therapy.
Jim graduated with honors with BS, MS, and PhD degrees in Electrical & Computer Engineering from the University of Illinois at Urbana-Champaign and holds numerous patents in hardware and software technology. He has completed executive education at the University of California Berkeley Haas School of Business and the MIT Sloan School of Management.